Indication

Benign Multiple Sclerosis

1 clinical trial

1 product

1 drug

Clinical trial

A Randomized, Double-Blind, Delayed Treatment, Placebo-Controlled Trial to Assess the Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy

Status: Recruiting, Estimated PCD: 2025-06-01

Product

Drug